Those on long-term metformin or PPIs should discuss monitoring requirements with their healthcare provider
If you intend to draw 10 units for a 0.25mg dose at 2.5 mg/mL, but your actual concentration is 2.78 mg/mL because you only added 1.8 mL, you are actually injecting 0.278mg
Vitamin B12 injections are generally considered safe and well-tolerated, with minimal side effects
MECHANISM CATEGORIES RESEARCH CONDITIONS SAFETY Side effects Nausea Vomiting Diarrhea Constipation Headache Injection-site reactions Boxed warning for thyroid C-cell tumors Known interactions Oral contraceptives (delayed gastric emptying) Insulin / sulfonylureas (hypoglycemia risk) Contraindications Personal/family history of medullary thyroid carcinoma Multiple endocrine neoplasia type 2 REGULATORY STATUS FDA Approved as Victoza (T2D, 2010) and Saxenda (chronic weight management, 2014)
Insufficient lactation safety data
TUE guidance documents including new regulations on glucocorticoids In order to assist physicians and athletes, WADA will update and publish shortly, on its website, the following guidance documents on managing TUEs to include the new regulations on glucocorticoids: General document on glucocorticoids and TUEs (to be available mid-October 2021) Checklists on a number of medical conditions for which glucocorticoids may be used (to be available early November 2021) TUE Physician Guidelines for TUE Committees on how to evaluate TUE requests for glucocorticoids for different medical conditions (to be available early November 2021) Educational resources In addition to the guidance documents listed above, WADA has provided, or will provide, a number of educational resources as part of its Code Implementation Support Program (CISP), which can be accessed on the Agencys Anti-Doping Education and Learning Platform (ADEL)
